Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$11.89 - $24.68 $535,050 - $1.11 Million
-45,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$27.38 - $42.21 $1.23 Million - $1.9 Million
45,000 New
45,000 $1.49 Million
Q2 2020

Aug 11, 2020

SELL
$10.37 - $20.64 $234,361 - $466,464
-22,600 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$9.63 - $17.14 $42,372 - $75,416
-4,400 Reduced 16.3%
22,600 $274,000
Q4 2019

Feb 14, 2020

SELL
$7.2 - $13.2 $83,520 - $153,120
-11,600 Reduced 30.05%
27,000 $356,000
Q3 2019

Oct 23, 2019

BUY
$8.95 - $15.72 $199,584 - $350,556
22,300 Added 136.81%
38,600 $345,000
Q2 2019

Aug 14, 2019

BUY
$14.61 - $22.45 $238,143 - $365,935
16,300 New
16,300 $259,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.